Cell line · CVCL_1183
DU4475
Cancer cell line, Homo sapiens. Breast carcinoma. 36 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. DU4475. Cell lines, record CVCL_1183. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_1183
On this page
Cell line
As Cellosaurus gives it.
- Name
- DU4475
- Accession
- CVCL_1183
- RRID
- RRID:CVCL_1183
- Synonyms
- Du4475, DU-4475, Du-4475, DU 4475, Du 4475, Duke University 4475
- Species
- Homo sapiens (Human)
- Sex
- Female
- Age at sampling
- 70Y
- Category
- Cancer cell line
- Diseases
- Breast carcinoma (NCIt C4872)
- Derived from
- Skin (metastatic)
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems1
| Problem | Cellosaurus's note |
|---|---|
| Caution | Reported by some sites and publications to originate from a 62 year old woman, but the cell line was established when she was 70 year old. |
Source Cellosaurus
Papers36
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Novel fenoterol derivatives as suppressors of ERK1/2 phosphorylation in melanoma. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| ZSTK3744, a Novel Aryl Hydrocarbon Receptor Agonist, Exhibits Efficacy against Chemotherapy-Resistant Triple-Negative Breast Cancer. | Cancer Res Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Cell-Penetrating Peptide-Mediated siRNA Targeting of LDHC Suppresses Tumor Growth in a Triple-Negative Breast Cancer Zebrafish Xenograft Model. | Pharmaceutics | 2026 | Its Methods give the RRID and name the line | PubMed | |
| LDAcoop: Integrating non-linear population dynamics into the analysis of clonogenic growth in vitro. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Acetalax and Bisacodyl for the Treatment of Triple-Negative Breast Cancer: A Combined Molecular and Preclinical Study. | Cancer Res Commun | 2025 | Its Methods give the RRID and name the line | PubMed | |
| MILIP Binding to tRNAs Promotes Protein Synthesis to Drive Triple-Negative Breast Cancer. | Cancer Res | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Targeted MDM2 Degradation Reveals a New Vulnerability for p53-Inactivated Triple-Negative Breast Cancer. | Cancer Discov | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Carboxyl-terminal modulator protein facilitates tumor metastasis in triple-negative breast cancer. | Cancer Gene Ther | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Pan-cancer proteomic map of 949 human cell lines. | Cancer Cell | 2022 | Cellosaurus cites it | PubMed | |
| YKL-40 protein expression in human tumor samples and human tumor cell line xenografts: implications for its use in tumor models. | Cell Oncol (Dordr) | 2021 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 36
See all 36 papersRelatives1
| Relation | Cell line | Accession | Problem |
|---|---|---|---|
| Derived from it | DU4475/Cas9-hyg | CVCL_C9CJ |
Source Cell lines
Cell banks5
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | CRL-7921 | Discontinued | Cellosaurus |
| ATCC | HTB-123 | ATCC | |
| CLS | 300371 | CLS | |
| DSMZ | ACC-427 | DSMZ | |
| NCI-DCTD | DU4475 | Cellosaurus |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_1183
GET https://conductscience.org/api/cell-lines/v1/CVCL_1183/papers?page=2